Abeona TherapeuticsABEO

那斯達克 · USD
5.94
-0.05
(-0.75%)
收盤 08/18 03:59 (UTC+8)
盤後 
5.90 
5.90 
(-0.67%)
08/18 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • 0.25
  • -
  • 0.00
  • -
  • 0.26
  • 0.09
  • 0.11
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -65.96
  • 30.50
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
11,380
8,720
25,620
-
400
-
25,366
-
-
-
營業成本
4,1772,6961,044488------
營業毛利
7,203
6,024
24,576
-488
400
-
25,366
-
-
-
營業費用
20,85629,05747,48723,53023,192-42,038---
研發費用
5,0219,55526,8124,2165,9439,94134,3608,9419,2187,207
推銷及管理費用
15,83519,50218,78219,31417,1499,7867,6786,4048,6467,123
非經常性項目費用
--1,893-100-----
其他營業費用
----------
營業利益
-13,653
-23,033
-22,911
-24,018
-22,792
-19,727
-16,672
-15,345
-17,864
-14,330
其他收入及費用
-5,8426,7903,120-148,0948,6968,461-13,82226,342-16,296
利息費用
6968308849019579981,0821,1021,072952
稅前純益
-20,191
-17,073
-20,675
-20,358
124,345
-12,029
-9,293
-30,269
7,406
-31,578
所得稅
-2-215-15,19715,512-----
稅後純益
-20,191
-17,075
-20,460
-5,161
108,833
-12,029
-9,293
-30,269
7,406
-31,578
基本每股稅後盈餘(元)
-0.35-0.30-0.39-0.102.07-0.240.05-0.630.19-1.16
稀釋每股稅後盈餘(元)
-0.36-0.30-0.34-0.101.71-0.24-0.14-0.690.44-1.16
基本平均股數(千股)
57048.0056620.0055267.0054242.0052524.0049778.0048786.0048081.0040010.0027315.00
稀釋平均股數(千股)
57048.0056620.0093883.0054242.0066640.0049778.0037570.0048081.0051226.0027315.00
還原基本每股稅後盈餘(元)
-0.35-0.30-0.39-0.102.07-0.240.05-0.630.19-1.16
還原稀釋每股稅後盈餘(元)
-0.36-0.30-0.34-0.101.71-0.24-0.14-0.690.44-1.16
還原基本平均股數(千股)
57,04856,62055,26754,24252,52449,77848,78648,08140,01027,315
還原稀釋平均股數(千股)
57,04856,62093,88354,24266,64049,77837,57048,08151,22627,315
EBITDA(千元)
-18,585-15,361-18,012-18,569125,905-9,761-7,213-28,3259,156-29,961

大家都在看

HOT